¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Speech Recognition Software"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® recognition, perception ÇÑ±Û ÀÎÁö, ÀνÄ, ÀçÀνÄ
¼³¸í   
  »ýü°¡ Àڱ⠶Ǵ Àڱ⿡°Ô ÀûÇÕÇÑ °ÍÀ¸·Î ºñÀڱ⸦ ½Äº°Çϴ °Í. »ýü°¡ ¾î¶°ÇÑ ÀÚ±ØÀ» ¼ö¿ëü µîÀ¸·Î ¼ö¿ëÇÏ¿© ½Äº°ÇÑ °á°ú ÀϾ º¯È­, ¹ÝÀÀ ¶Ç´Â Çൿ±îÁö¸¦ Æ÷ÇÔÇØ¼­ ¸»Çϴ °æ¿ìµµ ÀÖ´Ù. Ç׿øÀÚ±ØÀ» ¹ÞÀº ¸é¿ª´ã´ç¼¼Æ÷¿¡ ÀϾ´Â º¯È­¿Í °°Àº ¹°Áú¼öÁØÀÇ Çö»óÀ¸·ÎºÎÅÍ °íµîµ¿¹°¿¡¼­ °³Ã¼ÀÇ ÀÎÁö µîÀÌ ÀÖ´Ù. ¶ÇÇÑ º¸´Ù °íÂ÷ÀÇ Ãß»óÀûÀΠ°³³äÀ¸·Î¼­ °¨°¢¿¡ À־ÀÇ ÀÎÁö³ª ÁßÃ߽ŰæÀÇ ´É·Â¿¡ °ü¿©Çϴ ÆÐÅÏÀνĠµîÀÌ ÀÖ´Ù. 
¿µ¹® speech center ÇÑ±Û ¾ð¾îÁßÃß
¼³¸í   
  ¾ð¾îÀÇ »ý¼º°ú ÀÌÇØ¸¦ °üÀåÇϴ ´ë³ú°ÑÁúÀǠƯÁ¤ÇÑ ºÎÀ§. Àΰ£ÀǠƯ¡ÀΠ¾ð¾î´Â Æ¯Á¤ÇÑ »ó´ë¿Í ¸¶À½ÀÇ ³»¿ëÀ» ¼­·Î ÀüÇϱâ À§ÇØ ¾²´Â ¼Ò¸®ÀÌ´Ù. »ó´ë¹æÀ¸·ÎºÎÅÍ µéÀº ¼Ò¸®¸¦ Àǹ̰¡ Àִ ¾ð¾î·Î ÀÌÇØÇÏ°í ¸¶À½ÀÇ ³»¿ë¿¡ ´ëÀÀÇϴ ¾ð¾î¸¦ ¼Ò¸®·Î ³»´Â ¾ó°³¸¦ ¿µÀ§Çϴ °÷ÀÌ ¾ð¾îÁßÃßÀÌ´Ù. ´ë³ú¹Ý±¸ÀǠǥÃþ¿¡ Àִ ´ë³ú°ÑÁú¿¡ ¼¼ °³ÀÇ ¾ð¾îÁßÃß°¡ ÀÖ´Ù. ¿©±â¿¡ °ü¿©Çϴ ´ë³ú°ÑÁúÀÇ ¿µ¿ªÀ» ¾ð¾î¾ß(speech area)¶ó ÇÑ´Ù. ÀÌ ¿µ¿ªÀº Åë»óÀûÀ¸·Î ¿ÞÂÊ´ë³ú ¹Ý±¸¿¡ ÀÖ´Ù. ÁÖ¿ä ¿µ¿ªÀ¸·Î´Â ¿îµ¿¼º ¾ð¾îÁßÃß(ºê·ÎÄ« ÁßÃß)¿Í °¨°¢¼º ¾ð¾îÁßÃß(¿ö´ÏÄÉ ÁßÃß)°¡ ÀÖ´Ù. ¾ð¾î¾ß°¡ ¼Õ»óµÇ¸é ½Ç¾îÁõÀÌ »ý±ä´Ù. ¿îµ¿¼º ¾ð¾îÁßÃßÀÇ Àå¾Ö°¡ Àִ »ç¶÷Àº À̾߱⳪ ½áÀִ ±ÛÀڴ Àß ÀÌÇØÇÏÁö¸¸ ÀÚ¹ßÀûÀ¸·Î ¸»À» ÀßÇÒ ¼ö´Â ¾ø´Ù. À̰ÍÀ» ¿îµ¿¼º ½Ç¾îÁõÀ̶ó ÇÑ´Ù. °¨°¢¼º ¾ð¾îÁßÃßÀÇ Àå¾Ö°¡ Àִ »ç¶÷Àº Ã»°¢Àº Á¤»óÀûÀÓ¿¡µµ ºÒ±¸ÇÏ°í ¸»Çϴ ¾ð¾î³ª ¾²¿©Áø ¹®ÀÚÀÇ Àǹ̸¦ ¾Ë ¼ö ¾ø°Ô µÈ´Ù. À̰ÍÀ» °¨°¢¼º ½Ç¾îÁõÀ̶ó ÇÑ´Ù.
¿µ¹® speech therapy ÇÑ±Û ¾ð¾îÄ¡·á
¼³¸í   
  ¸»À» Á¤È®ÇϰԠ¹ßÀ½ÇÒ ¼ö ¾ø°Å³ª ´õµë´Â È¯ÀÚ¿¡°Ô ¹ßÀ½, ´ëÈ­ µûÀ§ÀÇ ÈÆ·ÃÀ» Àü¹®ÀûÀ¸·Î ÇàÇϴ ġ·á¹ý. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • speech recognition threshold
    ¾ð¾î°¨Áö¹®Åΰª
  • antigen recognition
    Ç׿øÀνÄ
  • antigen-recognition site
    Ç׿øÀÎÁöºÎÀ§
  • immunological recognition
    ¸é¿ªÀνÄ
  • pattern recognition
    ÆÐÅÏÀνÄ, ¸ð¾çÀνÄ
  • recognition
    1. ÀνÄ, ÀÎÁö 2. ½ÂÀÎ
  • self recognition
    ÀÚ±âÀνÄ
  • clipped speech
    ÀÚÀ½Å»¶ô¾ð¾î
  • cerebellar speech
    ¼Ò³ú¼º¸»Åõ
  • explosive speech
    Æø¹ßÀû¸»Åõ
  • esophageal speech
    ½Äµµ¹ß¼º
  • hearing speech clinic
    û°¢¾ð¾îÁø·á¼Ò
  • motor speech area
    ¿îµ¿¾ð¾î±¸¿ª
  • motor speech center
    ¿îµ¿¾ð¾îÁßÃß
  • nasal speech
    ºñ¼º¾î, ºñÀ½Áõ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • recognition
    ÀÎÁö, ÀνÄ
  • speech center
    ¾ð¾îÁßÃß
  • speech disturbance
    ¾ð¾îÀå¾Ö
  • speech discrimination
    ¾îÀ½¸í·áµµ, ¸»¼Ò¸®¸í·áµµ
  • speech hearing
    ¸»¼Ò¸®µè±â, ¾îÀ½Ã»·Â
  • speech
    ¾îÀ½, ¾ð¾î, ¸»¼Ò¸®
  • slurred speech
    ºÒ¸í·á¾ð¾î
  • speech therapy
    ¾ð¾îÄ¡·á
  • speech voice
    ¾ð¾îÀ½¼º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • speech recognition threshold
    ¾ð¾îÀÎÁö¹®ÅÎ
  • antigen recognition
    Ç׿øÀÎÁö
  • antigen-recognition site
    Ç׿øÀÎÁöºÎÀ§
  • dual recognition hypothesis
    Ç׿øÀÌÁßÀÎÁö°¡¼³
  • immunological recognition
    ¸é¿ªÀÎÁö
  • pattern recognition
    ÆÐÅÏÀνÄ, ¸ð¾çÀνÄ
  • recognition
    ÀÎÁö, ÀνÄ, ÀçÀνÄ
  • self recognition
    ÀÚ±âÀÎÁö
  • motor speech area
    ¿îµ¿¾ð¾î±¸¿ª
  • receptive speech area
    ¼ö¿ë¾ð¾îÁßÃß
  • speech aid
    ¹ßÀ½º¸Á¶±â
  • speech area
    ¾ð¾î±¸¿ª
  • speech articulation
    ¾ð¾î±¸À½
  • speech audiogram
    ¾îÀ½Ã»·Âµµ
  • speech audiometer
    ¾îÀ½Ã»·Â°è
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antialiasing software
    ¹Ý¿¡Àϸ®¾î½Ì ¼ÒÇÁÆ®¿þ¾î
  • antigen recognition
    Ç׿øÀÎÁö
  • antigen recognition site
    Ç׿ø½Äº°ºÎ.
  • immunological recognition
    ¸é¿ªÇÐÀûÀÎÁö
  • recognition
    ÀνÄ(ìããÛ).
  • recognition
    ÀÎÁö
  • recognition, self
    ÀÚ±âÀÎÁö
  • Brocas speech area
    ºê·ÎÄ«¾ð¾î¿µ¿ª
  • acoustic speech center
    û°¢(¼º) ¾ð¾îÁßÃß
  • hearing loss, speech
    ¾îÀ½Ã»·Â¼Õ½Ç
  • hearing speech clinic
    û°¢¾ð¾îŬ¸®´Ð
  • hearing test, speech
    ¾îÀ½Ã»·Â°Ë»ç
  • hearing, speech
    ¾îÀ½Ã»·Â
  • inner language =internal speech
    ³»¾ð¾î
  • pressured speech
    ¾ð¾î¾Ð¹Ú£¨åëåÞäâÚÞ£©
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • speech recognition thresholds
  • antialiasing software
    ¹Ý¿¡Àϸ®¾î½Ì ¼ÒÇÁÆ®¿þ¾î
  • software
    ¼ÒÇÁÆ®¿þ¾î
  • software
    ½ºÇÁÆ®¿þ¾î
  • antigen recognition
    Ç׿øÀÎÁö
  • antigen recognition site
    Ç׿ø½Äº°ºÎ.
  • dual recognition hypothesis
    Ç׿øÀÌÁßÀÎÁö°¡¼³
  • immunological recognition
    ¸é¿ªÇÐÀûÀÎÁö
  • pattern recognition
    ÆÐÅÏÀνÄ
  • pattern recognition
    ÆÐÅÏÀνÄ, ¸ð¾çÀνÄ.
  • recognition
    ÀÎÁö
  • recognition
    ÀνÄ(ìããÛ).
  • recognition, self
    ÀÚ±âÀÎÁö
  • acoustic speech center
    û°¢(¼º) ¾ð¾îÁßÃß
  • ataxic speech
    ½ÇÁ¶(¼º)¾ð¾î(¡­åëåÞ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • associative recognition
    ¿¬ÇÕ¼ºÀÎ½Ä (æáùêàõìããÛ)
  • dual recognition
    ÀÌÁß ÀνÄ(ì£ñììããÛ)
  • MHC associative recognition
    MHC ¿¬ÇÕÀÎÁö(Ö¤ùêìãò±)
  • multiple codon recognition
    ´Ù(Òý)ÄÚµ· ÀÎÁö(ìãò±)
  • recognition site
    ÀνÄ(ìããÛ)ÀÚ¸®
  • signal recognition protein
    ½ÅÈ£ÀÎÁö´Ü¹éÁú(ãáûÜìãò±Ó±ÛÜòõ)
  • tRNA synthetase recognition site
    tRNA½ÅÅ×Å×À̽º ÀÎÁö(ìãò±)ÀÚ¸®
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antialiasing software
    ¹Ý¿¡Àϸ®¾î½Ì ¼ÒÇÁÆ®¿þ¾î
  • pattern recognition
    ÆÐÅÏÀνÄ, ¸ð¾çÀνÄ
  • recognition
    ÀÎÁö, ÀνÄ
  • software
    ½ºÇÁÆ®¿þ¾î
  • motor speech area
    ¿îµ¿¾ð¾î·É
  • speech
    ¾ð¾î
  • speech area
    ¾ð¾î¿µ¿ª
  • speech center
    ¾ð¾îÁßÃß
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SRT sedimentation rate test; simple reaction time; sinus node recovery time; sitting root test; speech r...
SET-N software evaluation tool for nursing
ARAM antigen recognition activation motif
CEARP Continuing Education Approval and Recognition Program
CERP Continuing Education Recognition Program
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SRT Speech recognition threshold
CRD Carbohydrate recognition domain
FRT FLP recognition target
MARE Maf recognition element
ORC Origin Recognition Complex
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • antialiasing software
    ¹Ý¿¡Àϸ®¾î½Ì ¼ÒÇÁÆ®¿þ¾î
  • software
    ½ºÇÁÆ®¿þ¾î
  • antigen recognition site
    Ç׿ø ½Äº°ºÎ
  • dual recognition hypothesis
    2Áß Àνļ³
    ¸é¿ª ¼¼Æ÷ »çÀÌÀÇ »óÈ£ ÀÛ¿ë¿¡ À־ÀÇ T ¼¼Æ÷ÀÇ ÀÎ½Ä ±â±¸¿¡ °üÇÑ °¡¼³ÀÇ Çϳª. T ¼¼Æ÷¿¡´Â ÀÚ±âÀÇ MHC ºÐÀÚ¸¦ ÀνÄÇϱâ À§ÇÑ ¼ö¿ëü¿Í ´Ù¸¥ °ÍÀ» ÀνÄÇϱâ À§ÇÑ ¼ö¿ëü°¡ °¢°¢ µ¶¸³ÇÏ¿© Á¸ÀçÇÑ´Ù°í ÇÏ´Â »ý°¢.
  • recognition site
    ÀÎ½Ä ºÎÀ§
  • binaural distorted speech test
    ¾çÀÌ¿ÖÈ­ ½ÃÇè
  • development of speech and language
    ÀÇ»ç ¼ÒÅëÀÇ ¹ß´Þ
  • disturbance of speech
    ¾ð¾î Àå¾Ö
  • esopahgeal speech
    ½Äµµ ¾ð¾î
    ÈĵΠÀýÁ¦¼ú ÈÄ¿¡ ½Äµµ³»ÀÇ °ø±â°¡ ÇùÂøµÈ À±»ó ÀεΠ°ý¾à±Ù¿¡ ´ëÇØ¼­ Áøµ¿µÇ¾î ¹ß»ýµÇ´Â ¾ð¾î.
  • motor speech center
    ¿îµ¿¼º ¾ð¾î ÁßÃß
  • nasal speech
    ºñ¼º¾î, ºñÀ½Áõ
  • optic speech center
    ½Ã°¢ ¾ð¾î ÁßÃß, ½Ã°¢¼º ¾ð¾î ÁßÃß
  • organ of speech
    ¾ð¾î ±â°ü
  • pressured speech
    ¾Ð·Â ¾ð¾î
    ºü¸£°í, °¡¼ÓÈ­µÇ°í, °Ý¾ÓµÈ ¾ð¾î·Î¼­, ¹ß¼º ±ÙÁ¶Á÷ÀÌ ¹ß¼ºÇÒ ¼ö ÀÖ´Â ´É·ÂÀ» ÃʰúÇϰí, Á¶¸®°¡ ¸ÂÁö ¾Ê°Ô µé¸°´Ù.
  • prosthetic speech aid
    º¸Ã¶ ¹ßÀ½ º¸Á¶±â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
software Sequential operating instructions for a particular problem or function to be run on a digital computer.
(12 Dec 1998)
software design Specifications and instructions applied to the software.
(12 Dec 1998)
software validation The act of testing the software for compliance with a standard.
(12 Dec 1998)
recognition factors Factors which effect "recognition" of target antigens by polymorphonuclear leukocytes; apparently the Fc portion of antibody molecules and the activated third component of complement (C3), for both of which phagocytes have receptor sites.
(05 Mar 2000)
recognition sequence A nucleotide sequence --typically composed of 4, 6, or 8nucleotides -- that is recognised by a restriction endonuclease. Type II enzymes cut (and theircorresponding modification enzymes methylate) within or very near the recognition sequence.
(09 Oct 1997)
recognition time The interval between the application of a stimulus and the recognition of its nature.
(05 Mar 2000)
pattern recognition In information retrieval, machine-sensing or identification of visible patterns (shapes, forms, and configurations). (harrod's librarians' glossary, 7th ed)
(12 Dec 1998)
pattern recognition, visual Visually perceived characters, shapes, displays, or designs.
(12 Dec 1998)
cell recognition <cell biology> Interaction between cells that is possibly dependent upon specific adhesion. Since the mechanism is not entirely clear in most cases, the term should be used with caution.
(26 Mar 1998)
signal recognition particle A complex between a 7S RNA and six proteins. SRP binds to the nascent polypeptide chain of eukaryotic proteins with a signal sequence and halts further translation until the ribosome becomes associated with the rough endoplasmic reticulum. One of the SRP proteins (srp54) binds GTP and in association with 7SRNA and srp19 has GTPase activity.
(18 Nov 1997)
signal recognition particle receptor Receptor for the signal recognition particle (SRP) found in the membrane of the endoplasmic reticulum. Also called docking protein. Heterodimeric, both protomers having GTP binding capacity, though dissimilar binding sites. Not until the complex of SRP, ribosome, message and nascent polypeptide chain binds to the SRP receptor is the block to further chain elongation released and concurrently the SRP is released, leaving the ribosome attached to the endoplasmic reticulum membrane. Cotranslational transport of the polypeptide delivers it into the lumen of the ER.
(18 Nov 1997)
dual recognition hypothesis An outmoded hypothesis that is known to be incorrect now that the structure of the T-cell receptor is known. The proposal was that viral (and some chemical) antigens were recognised in association with histocompatibility antigens by separate receptors on the T-cell. The generation of cytotoxic T-cells was by association with Class I MHC antigens, of T helper cells by association with Class II MHC antigens.
See: altered self hypothesis.
(18 Nov 1997)
alaryngeal speech A form of speech achieved after laryngectomy by using either an external vibratory source or the pharyngoesophageal segment as an internal vibratory source. Tracheoesophageal speech may be produced after laryngectomy by surgically diverting exhaled air to the pharynx by a permanently constructed tracheoesophageal fistula.
(05 Mar 2000)
american speech-language-hearing association A professional society concerned with the diagnosis, prevention, treatment, and remediation of speech, language, and hearing disorders.
(12 Dec 1998)
audiometry, speech Measurement of the ability to hear speech under various conditions of intensity and noise interference using sound-field as well as earphones and bone oscillators.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Speech Recognition Software - »õâ Software capable of recognizing dictation and transcribing the spoken words into written text.
    Synonyms : Recognition Software, Speech, Recognition Software, Voice, Software, Speech Recognition, Software, Voice Recognition
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • software
    ¼ÒÇÁÆ®¿þ¾î(ÇÁ·Î±×·¥ ü°èÀÇ ÃÑĪ);(·ÎÄÏ,¹Ì»çÀÏÀÇ)¼³°è;¿¬·á(µûÀ§)
  • recognition
    µ¿ÀÏ(½Ã); ÀÎÁ¤; ½ÂÀÎ
  • recognition
    ÀνÄ;ÀÎÁ¤;ÀÎÁö;½ÂÀÎ;(°ø·Î µîÀ»)¾Ë¾ÆÁÜ;ǥâ;º¸¼ö;º¸´ä;»ç·Ê;¾Ë¾Æº½;¸é½Ä;Àλç;Àý
  • speech
    ¿¬¼³,¾ð¾î,À̾߱â
  • campaign speech
    Á¤°ß ¹ßÇ¥;¼±°Å ¿¬¼³
  • cued speech
    ±¸È­¿Í ¼öÈ­¸¦ Á¶ÇÕÇÑ ³ó¾ÆÀÚ¸¦ À§ÇÑ ¾ð¾î Àü´Þ¹ý ES
  • curtain speech
    (¿¬±Ø Á¾·á ÈÄ)¸· ¾Õ¿¡¼­ÀÇ Àλ縻;¿¬±Ø(¸·.Àå)ÀÇ ¸¶Áö¸· ´ë»ç
  • direct speech
    (¹®¹ý)=DIRECT NARRATION
  • free speech
    ÀÚÀ¯ ¾ð·Ð;¾ð·ÐÀÇ ÀÚÀ¯
  • indirect speech
    (¿µ)INDIRECT DISCOURSE
  • inner speech form
    ³»ºÎ ¾ð¾î Çü½Ä
  • reported speech
    °£Á¢ È­¹ý;ÇÇÀü´ÞºÎ
  • represented speech
    ¹¦ÃâÈ­¹ý(Á÷Á¢È­¹ý°ú °£Á¢È­¹ýÀÇ Áß°£Àû ¼ºÁúÀ» °¡Áø)
  • robot speech
    Àΰø ÇÕ¼º À½¼º(synthetic speech)
  • speech
    ¸»;¾ð¾î ±¹¾î ¹æ¾ð;Ç¥Çö·Â;À̾߱â;´ãÈ­;¸»Åõ;¾ð¾î´É·Â;¿¬¼³;¿¬¼³¹ý;È­¹ý
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á